Atorvastatin Calcium
Product Images NDC 82239-001

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82239-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by August Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-10mg-01 (Atorvastatin 10mg 01)

Label for Atorvastatin Calcium Tablets, USP 10 mg, containing 30 film-coated tablets. The label states storage instructions at controlled room temperature 20-25°C (68-77°F) and dispensing in tight containers. Manufactured by Halo Pharmaceutical Canada, Inc. and distributed by August Pharmaceutical, LLC, located in Fairfield, NJ. Includes NDC 82239-001-01 and a barcode on the right side.*

FDA Label Image

Atorvastatin-10mg-02 (Atorvastatin 10mg 02)

The label for Atorvastatin Calcium Tablets, USP shows 10 mg strength in film-coated tablet form, with 90 tablets in the package. Manufactured by Halo Pharmaceutical Canada and distributed by August Pharmaceutical, LLC, the label includes storage instructions and a barcode. The product is prescription only.*

FDA Label Image

Atorvastatin-10mg-04 (Atorvastatin 10mg 04)

Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets label showing 1000 tablets in the package. Label indicates the product is manufactured by Halo Pharmaceutical Canada, Inc. and distributed by August Pharmaceutical, LLC. Includes storage instructions and a barcode for scanning.*

FDA Label Image

Atorvastatin-10mg-3 (Atorvastatin 10mg 3)

Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets label showing the product name, strength, and dosage form. The label indicates a package size of 500 tablets and specifies Rx only. Manufactured by Halo Pharmaceutical Canada, Inc., and distributed by August Pharmaceutical, LLC. Storage instructions include controlled room temperature 20-25°C (68-77°F). The label features a barcode along with lot and expiration date fields.*

FDA Label Image

Atorvastatin-20mg-01 (Atorvastatin 20mg 01)

Label for Atorvastatin Calcium Tablets, USP 20 mg film-coated tablets, distributed by August Pharmaceutical, LLC. The label states each tablet contains atorvastatin calcium equivalent to 20 mg atorvastatin, with a package size of 90 tablets. It includes storage instructions, manufacturer information (Halo Pharmaceutical Canada, Inc), and a barcode.*

FDA Label Image

Atorvastatin-20mg-04 (Atorvastatin 20mg 04)

Atorvastatin Calcium Tablets, USP 20 mg film-coated tablets label shows the product name, strength, and quantity of 1000 tablets. Manufactured by Halo Pharmaceutical Canada, Inc and distributed by August Pharmaceutical, LLC. The label includes storage instructions, a barcode, and NDC 82239-002-04.*

FDA Label Image

Atorvastatin-20mg-1 (Atorvastatin 20mg 1)

Atorvastatin Calcium Tablets, USP 20 mg film-coated tablets label showing the active ingredient atorvastatin calcium equivalent to 20 mg atorvastatin. The label includes storage instructions, dosage directions to see package insert, manufacturer information (Halo Pharmaceutical Canada, Inc.), distributor details (August Pharmaceutical, LLC), package size of 30 tablets, and an NDC barcode.*

FDA Label Image

Atorvastatin-20mg-03 (Atorvastatin 20mg 3)

Label of Atorvastatin Calcium Tablets, USP 20 mg by August Pharmaceutical, LLC. Contains 500 film-coated tablets. Manufactured by Halo Pharmaceutical Canada, Inc. Storage instructions include maintaining controlled room temperature 20-25°C. The label includes a barcode, NDC 82239-002-03, and distribution address in Fairfield, NJ.*

FDA Label Image

Atorvastatin-40mg-01 (Atorvastatin 40mg 01)

Label for Atorvastatin Calcium Tablets, USP 40 mg distributed by August Pharmaceutical, LLC. The label states each film-coated tablet contains atorvastatin calcium equivalent to 40 mg atorvastatin, with a package size of 30 tablets. It includes storage instructions (20-25°C), manufacturer details (Halo Pharmaceutical Canada, Inc), a barcode, and space for lot and expiration dates.*

FDA Label Image

Atorvastatin-40mg-02 (Atorvastatin 40mg 02)

Label for Atorvastatin Calcium Tablets, USP 40 mg distributed by August Pharmaceutical, LLC. The label indicates the product contains 40 mg of atorvastatin per tablet and comes in a bottle of 90 tablets. It includes storage instructions to keep at controlled room temperature (20-25°C) and notes the manufacturer as Halo Pharmaceutical Canada, Inc. The label features a barcode, NDC 82239-003-02, and states the product is prescription only.*

FDA Label Image

Atorvastatin-40mg-03 (Atorvastatin 40mg 03)

Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets packaging label. The label states 500 tablets per container, distributed by August Pharmaceutical, LLC, and manufactured by Halo Pharmaceutical Canada, Inc. The label includes storage information, prescription-only designation, and a barcode with NDC 82239-003-03.*

FDA Label Image

Atorvastatin-40mg-04 (Atorvastatin 40mg 04)

Label for Atorvastatin Calcium Tablets, USP 40 mg, manufactured by Halo Pharmaceutical Canada, Inc. and distributed by August Pharmaceutical, LLC. The label states the NDC 82239-003-04 and package size of 1000 tablets. It includes storage instructions to keep at controlled room temperature 20-25°C and dispensing in tight containers. Barcode and distribution address in Fairfield, NJ are shown.*

FDA Label Image

Atorvastatin-80mg-01 (Atorvastatin 80mg 01)

Label for Atorvastatin Calcium Tablets, USP 80 mg. The label shows the drug name and strength prominently, specifies the package contains 30 tablets, and notes 'Rx only'. It includes manufacturer information: Halo Pharmaceutical Canada, Inc., and distributor August Pharmaceutical, LLC with address in Fairfield, NJ. Storage instructions and dosing reference to package insert are provided, along with an NDC number 82239-004-01 and barcode.*

FDA Label Image

Atorvastatin-80mg-02 (Atorvastatin 80mg 02)

Label for Atorvastatin Calcium Tablets, USP 80 mg by August Pharmaceutical, LLC. The label indicates the tablets are film-coated, supplied in a 90 count container, and are Rx only. Manufactured by Halo Pharmaceutical Canada, Inc. The label includes storage instructions to keep at controlled room temperature 20-25°C (68-77°F), dosage and use referencing the package insert, and barcode with distributor address in Fairfield, NJ.*

FDA Label Image

Atorvastatin-80mg-03 (Atorvastatin 80mg 03)

Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets label showing a 500-count container. Manufactured by Halo Pharmaceutical Canada, Inc., and distributed by August Pharmaceutical, LLC. Storage instructions indicate controlled room temperature at 20-25°C (68-77°F). Includes NDC 82239-004-03 and barcode on the right side.*

FDA Label Image

Atorvastatin-80mg-04 (Atorvastatin 80mg 04)

Label for Atorvastatin Calcium Tablets, USP 80 mg, containing 1000 film-coated tablets. The label includes storage instructions at 20-25°C (68-77°F) and states the drug is prescription only. Manufactured by Halo Pharmaceutical Canada, Inc. and distributed by August Pharmaceutical, LLC. It features an NDC barcode and space for lot and expiration information.*

FDA Label Image

Atorvastatin-fi1-jpg.jpg (Atorvastatin Fi1 Jpg)

A line graph depicting the cumulative incidence (%) over a period of up to 3.5 years for Atorvastatin compared to placebo. The graph shows two lines, one solid for Atorvastatin and one dashed for placebo, illustrating differences in cumulative incidence rates over time with accompanying hazard ratio and p-value data.*

FDA Label Image

Atorvastatin-fi2-jpg.jpg (Atorvastatin Fi2 Jpg)

A line graph showing the cumulative hazard percentage over time from 0 to 5 years, comparing placebo and atorvastatin groups. The X-axis represents years of follow-up until the first primary endpoint, while the Y-axis shows cumulative hazard percentages. The graph indicates lower hazard in the atorvastatin group versus placebo, with a hazard ratio of 0.63 and a p-value of 0.001.*

FDA Label Image

Atorvastatin-fig3-jpg.jpg (Atorvastatin Fig3 Jpg)

Line chart comparing the percentage of subjects experiencing a first major cardiovascular event over five years between Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing events. The graph includes a hazard ratio (HR) of 0.78 with a 95% confidence interval and a p-value of 0.0002.*

FDA Label Image

Atorvastatin-structure (Atorvastatin Molstructure Jpg)

Chemical structure of atorvastatin calcium showing the arrangement of its molecular components including phenyl, fluorophenyl, and other functional groups, complexed with calcium ions and water molecules as indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.